Paliperidone palmitate post-authorisation safety study
This project is part of a wider multi-site investigation of safety and adverse events associated with paliperidone palmitate – a relatively new long-acting injectable antipsychotic medication. The investigation is focusing on cardiovascular and cerebrovascular events in older people receiving this treatment.